Atherosclerosis and tumor suppressor molecules (Review)

Suzuki,Miho; Minami,Akari; Nakanishi,Atsuko; Kobayashi,Keiko; Matsuda,Satoru; Ogura,Yasunori; Kitagishi,Yasuko

doi:10.3892/ijmm.2014.1866

Atherosclerosis and tumor suppressor molecules (Review)

Authors:
- Miho Suzuki
- Akari Minami
- Atsuko Nakanishi
- Keiko Kobayashi
- Satoru Matsuda
- Yasunori Ogura
- Yasuko Kitagishi
View Affiliations

Affiliations: Department of Food Science and Nutrition, Nara Women's University, Nishimachi, Nara 630-8506, Japan
Published online on: July 25, 2014 https://doi.org/10.3892/ijmm.2014.1866
Pages: 934-940

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Atherosclerosis, the major cause of heart attack and stroke, is a chronic inflammatory disease characterized by the formation of atherosclerotic plaque. Oxidized low-density lipoprotein through increased oxidative stress has been identified as one of the primary factors responsible for atherogenesis. Cell proliferation and death are key processes in the progression of atherosclerosis. The oxidative environment in areas of lipid accumulation is mainly created by the production of reactive oxygen species, which are assumed to mediate vascular tissue injury. Oxidative DNA damage and levels of DNA repair are reduced during dietary lipid lowering. The tumor suppressor molecules play a pivotal role in regulating cell proliferation, DNA repair and cell death, which are important processes in regulating the composition of atherosclerotic plaque. Accordingly, in this review, we discuss the fundamental role of tumor suppressor molecules in regulating atherogenesis. In particular, we discuss how tumor suppressor molecules are activated in the complex environment of atherosclerotic plaque, and regulate growth arrest, cell senescence and the apoptosis of vascular smooth muscle cells, which may protect against the progression of atherosclerosis. In addition, we discuss promising alternatives to the use of medications (such as statin) against atherosclerosis, namely diet, with the use of plant-derived supplements to modulate the expression and/or activity of tumor suppressor molecules. We also summarize the progress of research made on herbs with a focus on the modulatory roles of tumor suppressors, and on the molecular mechanisms underlying the prevention if atherosclerosis, supporting designs for further research in this field.

View Figures

View References

1	Libby P: Inflammation in atherosclerosis. Nature. 420:868–874. 2002. View Article : Google Scholar
2	Spagnoli LG, Bonanno E, Sangiorgi G and Mauriello A: Role of inflammation in atherosclerosis. J Nucl Med. 48:1800–1815. 2007. View Article : Google Scholar : PubMed/NCBI
3	Curtiss LK and Tobias PS: The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis. Curr Drug Targets. 8:1230–1238. 2007. View Article : Google Scholar : PubMed/NCBI
4	Cicchi R, Matthäus C, Meyer T, Lattermann A, Dietzek B, Brehm BR, Popp J and Pavone FS: Characterization of collagen and cholesterol deposition in atherosclerotic arterial tissue using non-linear microscopy. J Biophotonics. 7:135–143. 2014. View Article : Google Scholar : PubMed/NCBI
5	Pakala R, Rha SW, Kuchulakanti PK, Cheneau E, Baffour R and Waksman R: Peroxisome proliferator-activated receptor gamma; Its role in atherosclerosis and restenosis. Cardiovasc Radiat Med. 5:44–48. 2004. View Article : Google Scholar : PubMed/NCBI
6	Bays HE: Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: treating ‘sick fat’ through improving fat function with antidiabetes therapies. Am J Cardiol. 110:B4–B12. 2012.PubMed/NCBI
7	Blüher M: Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes. 117:241–250. 2009.
8	Stoll BA: Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr. 53:83–87. 1999. View Article : Google Scholar : PubMed/NCBI
9	Kligerman AD, Malik SI and Campbell JA: Cytogenetic insights into DNA damage and repair of lesions induced by a monomethylated trivalent arsenical. Mutat Res. 695:2–8. 2010. View Article : Google Scholar : PubMed/NCBI
10	Lin FY, Lin YW, Huang CY, Chang YJ, Tsao NW, Chang NC, Ou KL, Chen TL, Shih CM and Chen YH: GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, induces lectin-like oxidized low-density lipoprotein receptor 1 expression in endothelial cells and enhances atherogenesis in hypercholesterolemic rabbits. J Immunol. 186:4405–4414. 2011. View Article : Google Scholar
11	Dai Y, Mercanti F, Dai D, Wang X, Ding Z, Pothineni NV and Mehta JL: LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells. Biochem Biophys Res Commun. 437:62–66. 2013. View Article : Google Scholar : PubMed/NCBI
12	Dickhout JG, Basseri S and Austin RC: Macrophage function and its impact on atherosclerotic lesion composition, progression, and stability: the good, the bad, and the ugly. Arterioscler Thromb Vasc Biol. 28:1413–1415. 2008. View Article : Google Scholar : PubMed/NCBI
13	Edlin RS, Tsai S, Yamanouchi D, Wang C, Liu B and Kent KC: Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: potential role of Smad3 in regulation of SMC proliferation. J Vasc Surg. 49:1289–1295. 2009. View Article : Google Scholar : PubMed/NCBI
14	Humphries SE and Ordovas JM: Genetics and atherosclerosis: broadening the horizon. Atherosclerosis. 154:517–519. 2001. View Article : Google Scholar : PubMed/NCBI
15	Mercer J and Bennett M: The role of p53 in atherosclerosis. Cell Cycle. 5:1907–1909. 2006. View Article : Google Scholar : PubMed/NCBI
16	Khanna AK: Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis. J Biomed Sci. 15:16–66. 2009.PubMed/NCBI
17	Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G and Opie L: Cardiovascular remodelling in coronary artery disease and heart failure. Lancet. 383:1933–1943. 2014. View Article : Google Scholar : PubMed/NCBI
18	Mak AS: p53 in cell invasion, podosomes, and invadopodia. Cell Adh Migr. Feb 18–2014.(Epub ahead of print).
19	Ishii N, Matsumura T, Kinoshita H, Motoshima H, Kojima K, Tsutsumi A, Kawasaki S, Yano M, Senokuchi T, Asano T, Nishikawa T and Araki E: Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation. J Biol Chem. 284:34561–34569. 2009. View Article : Google Scholar
20	Anderson JL, Ashwell CM, Smith SC, Shine R, Smith EC and Taylor RL Jr: Atherosclerosis-susceptible and atherosclerosis-resistant pigeon aortic cells express different genes in vivo. Poult Sci. 92:2668–2680. 2013. View Article : Google Scholar : PubMed/NCBI
21	Liu WM, Scott KA, Thompson M and Dalgleish AG: Dendritic cell phenotype can be improved by certain chemotherapies and is associated with alterations to p21(waf1/cip1.). Cancer Immunol Immunother. 62:1553–1561. 2013. View Article : Google Scholar : PubMed/NCBI
22	Kim HJ, Yoo EK, Kim JY, Choi YK, Lee HJ, Kim JK, Jeoung NH, Lee KU, Park IS, Min BH, Park KG, Lee CH, Aronow BJ, Sata M and Lee IK: Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells. Arterioscler Thromb Vasc Biol. 29:1558–1564. 2009. View Article : Google Scholar
23	Obikane H, Abiko Y, Ueno H, Kusumi Y, Esumi M and Mitsumata M: Effect of endothelial cell proliferation on atherogenesis: a role of p21(Sdi/Cip/Waf1) in monocyte adhesion to endothelial cells. Atherosclerosis. 212:116–122. 2010. View Article : Google Scholar : PubMed/NCBI
24	Breitenstein A, Akhmedov A, Camici GG, Lüscher TF and Tanner FC: p27(Kip1) inhibits tissue factor expression. Biochem Biophys Res Commun. 439:559–563. 2013. View Article : Google Scholar : PubMed/NCBI
25	Conte MS, Owens CD, Belkin M, Creager MA, Edwards KL, Gasper WJ, Kenagy RD, LeBoeuf RC, Sobel M and Clowes A: A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts. J Vasc Surg. 57:1179–1185. 2013. View Article : Google Scholar : PubMed/NCBI
26	Díez-Juan A, Pérez P, Aracil M, Sancho D, Bernad A, Sánchez-Madrid F and Andrés V: Selective inactivation of p27(Kip1) in hematopoietic progenitor cells increases neointimal macrophage proliferation and accelerates atherosclerosis. Blood. 103:158–161. 2004.
27	Shahzad K, Thati M, Wang H, Kashif M, Wolter J, Ranjan S, He T, Zhou Q, Blessing E, Bierhaus A, Nawroth PP and Isermann B: Minocycline reduces plaque size in diet induced atherosclerosis via p27(Kip1). Atherosclerosis. 219:74–83. 2011. View Article : Google Scholar : PubMed/NCBI
28	Lange M, Fujikawa T, Koulova A, Kang S, Griffin MJ, Lassaletta AD, Erat A, Tobiasch E, Bianchi C, Elmadhun N, Sellke FW and Usheva A: Arterial territory-specific phosphorylated retinoblastoma protein species and CDK2 promote differences in the vascular smooth muscle cell response to mitogens. Cell Cycle. 13:315–323. 2014. View Article : Google Scholar
29	Faber AC and Chiles TC: Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas. Cell Cycle. 6:2982–2989. 2007. View Article : Google Scholar : PubMed/NCBI
30	Ma KL, Liu J, Wang CX, Ni J, Zhang Y, Wu Y, Lv LL, Ruan XZ and Liu BC: Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Cardiovasc Res. 100:450–460. 2013. View Article : Google Scholar : PubMed/NCBI
31	Boesten LS, Zadelaar AS, van Nieuwkoop A, Hu L, Jonkers J, van de Water B, Gijbels MJ, van der Made I, de Winther MP, Havekes LM and van Vlijmen BJ: Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice. FASEB J. 20:953–955. 2006. View Article : Google Scholar : PubMed/NCBI
32	Chen WJ, Lin KH, Lai YJ, Yang SH and Pang JH: Protective effect of propylthiouracil independent of its hypothyroid effect on atherogenesis in cholesterol-fed rabbits: PTEN induction and inhibition of vascular smooth muscle cell proliferation and migration. Circulation. 110:1313–1319. 2004. View Article : Google Scholar : PubMed/NCBI
33	Yuan M, Wang X, Zhan Q, Duan X, Yang Q and Xia J: Association of PTEN genetic polymorphisms with atherosclerotic cerebral infarction in the Han Chinese population. J Clin Neurosci. 19:1641–1645. 2012. View Article : Google Scholar : PubMed/NCBI
34	Kuo HM, Lin CY, Lam HC, Lin PR, Chan HH, Tseng JC, Sun CK, Hsu TF, Wu CC, Yang CY, Hsu CM and Tai MH: PTEN overexpression attenuates angiogenic processes of endothelial cells by blockade of endothelin-1/endothelin B receptor signaling. Atherosclerosis. 221:341–139. 2012. View Article : Google Scholar : PubMed/NCBI
35	Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, Xu J, Goldberg ID, Jaiswal AK and Rosen EM: BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res. 64:7893–7909. 2004. View Article : Google Scholar : PubMed/NCBI
36	Singh KK, Shukla PC, Quan A, Al-Omran M, Lovren F, Pan Y, Brezden-Masley C, Ingram AJ, Stanford WL, Teoh H and Verma S: BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis. J Thorac Cardiovasc Surg. 146:949–960. 2013. View Article : Google Scholar : PubMed/NCBI
37	Lovren F, Pan Y, Quan A, Singh KK, Khan R, Gupta N, Brezden-Masley C, Teoh H, Wheatcroft MD, Al-Omran M and Verma S: BRCA1 shields vascular smooth muscle cells from oxidative stress. J Thorac Cardiovasc Surg. 147:1946–1955. 2014. View Article : Google Scholar : PubMed/NCBI
38	Ozaki K, Sato H, Inoue K, Tsunoda T, Sakata Y, Mizuno H, Lin TH, Miyamoto Y, Aoki A, Onouchi Y, Sheu SH, Ikegawa S, Odashiro K, Nobuyoshi M, Juo SH, Hori M, Nakamura Y and Tanaka T: SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet. 41:329–333. 2009. View Article : Google Scholar : PubMed/NCBI
39	Jerome WG: Lysosomes, cholesterol and atherosclerosis. Clin Lipidol. 5:853–865. 2010. View Article : Google Scholar : PubMed/NCBI
40	Suzuki E, Takahashi M, Oba S and Nishimatsu H: Oncogene- and oxidative stress-induced cellular senescence shows distinct expression patterns of proinflammatory cytokines in vascular endothelial cells. ScientificWorldJournal. 2013:7547352013. View Article : Google Scholar
41	Boominathan L: The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network. Cancer Metastasis Rev. 29:613–639. 2010. View Article : Google Scholar : PubMed/NCBI
42	O’Neil N and Rose A: DNA repair. WormBook. 1–12. 2006.
43	Muller PA and Vousden KH: 53 mutations in cancer. Nat Cell Biol. 15:2–8. 2013. View Article : Google Scholar
44	Conforti F, Sayan AE, Sreekumar R and Sayan BS: Regulation of p73 activity by post-translational modifications. Cell Death Dis. 3:e2852012. View Article : Google Scholar : PubMed/NCBI
45	Appella E and Anderson CW: Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem. 268:2764–2772. 2001. View Article : Google Scholar : PubMed/NCBI
46	Hock AK and Vousden KH: The role of ubiquitin modification in the regulation of p53. Biochim Biophys Acta. 1843:137–149. 2014. View Article : Google Scholar : PubMed/NCBI
47	Mattila KJ, Valtonen VV, Nieminen MS and Asikainen S: Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis. 26:719–734. 1998. View Article : Google Scholar : PubMed/NCBI
48	Razani B, Feng C and Semenkovich CF: p53 is required for chloroquine-induced atheroprotection but not insulin sensitization. J Lipid Res. 51:1738–1746. 2010. View Article : Google Scholar : PubMed/NCBI
49	Martinet W, Knaapen MW, De Meyer GR, Herman AG and Kockx MM: Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res. 88:733–739. 2001. View Article : Google Scholar : PubMed/NCBI
50	Georgiev P, Dahm F, Graf R and Clavien PA: Blocking the path to death: anti-apoptotic molecules in ischemia/reperfusion injury of the liver. Curr Pharm Des. 12:2911–2921. 2006. View Article : Google Scholar : PubMed/NCBI
51	Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, Kinugawa S and Tsutsui H: Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardiovasc Res. 70:457–465. 2006. View Article : Google Scholar : PubMed/NCBI
52	Kim YC, Kitaura H, Taira T, Iguchi-Ariga SM and Ariga H: Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN. Int J Oncol. 35:1331–1341. 2009.PubMed/NCBI
53	Markiewicz E, Ledran M and Hutchison CJ: Remodelling of the nuclear lamina and nucleoskeleton is required for skeletal muscle differentiation in vitro. J Cell Sci. 118:409–420. 2005. View Article : Google Scholar : PubMed/NCBI
54	Wikman H and Kettunen E: Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer. Expert Rev Anticancer Ther. 6:515–530. 2006. View Article : Google Scholar : PubMed/NCBI
55	Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, Dedieu JF, Pastore C, Mahfoudi A, Denèfle P, Isner JM and Walsh K: p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11:1674–1689. 1997. View Article : Google Scholar : PubMed/NCBI
56	Condorelli G, Aycock JK, Frati G and Napoli C: Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. FASEB J. 15:2162–2170. 2001. View Article : Google Scholar
57	Merched AJ and Chan L: Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis. Circulation. 110:3830–3841. 2004. View Article : Google Scholar : PubMed/NCBI
58	Brader S and Eccles SA: Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori. 90:2–8. 2004.PubMed/NCBI
59	Musumeci M, Maccari S, Corritore E, Massimi A, Stati T, Marano G and Catalano L: Signaling pathway-focused gene expression profiling in pressure overloaded hearts. Ann Ist Super Sanita. 47:290–295. 2011.PubMed/NCBI
60	Ouimet M: Autophagy in obesity and atherosclerosis: Interrelationships between cholesterol homeostasis, lipoprotein metabolism and autophagy in macrophages and other systems. Biochim Biophys Acta. 1831:1124–1133. 2013. View Article : Google Scholar
61	Yao PM and Tabas I: Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J Biol Chem. 275:23807–23813. 2000. View Article : Google Scholar : PubMed/NCBI
62	Waters SM, Coyne GS, Kenny DA and Morris DG: Effect of dietary n-3 polyunsaturated fatty acids on transcription factor regulation in the bovine endometrium. Mol Biol Rep. 41:2745–2755. 2014. View Article : Google Scholar : PubMed/NCBI
63	Merched AJ, Williams E and Chan L: Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling. Arterioscler Thromb Vasc Biol. 23:1608–1614. 2003. View Article : Google Scholar : PubMed/NCBI
64	Lee SJ, Park K, Ha SD, Kim WJ and Moon SK: Gleditsia sinensis thorn extract inhibits human colon cancer cells: the role of ERK1/2, G2/M-phase cell cycle arrest and p53 expression. Phytother Res. 24:1870–1876. 2010. View Article : Google Scholar
65	Lee SJ, Park SS, Kim WJ and Moon SK: Gleditsia sinensis thorn extract inhibits proliferation and TNF-α-induced MMP-9 expression in vascular smooth muscle cells. Am J Chin Med. 40:373–386. 2012. View Article : Google Scholar
66	Lu Y, Li CS and Dong Q: Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes. J Exp Clin Cancer Res. 27:312008. View Article : Google Scholar : PubMed/NCBI
67	Li B, Zhao J, Wang CZ, et al: Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 301:185–192. 2011. View Article : Google Scholar : PubMed/NCBI
68	Gali-Muhtasib H, Diab-Assaf M, Boltze C, et al: Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol. 25:857–866. 2004.PubMed/NCBI
69	Lee SJ, Kim HM, Cho YH, et al: Aqueous extract of Magnolia officinalis mediates proliferative capacity, p21WAF1 expression and TNF-α-induced NF-κB activity in human urinary bladder cancer 5637 cells; involvement of p38 MAP kinase. Oncol Rep. 18:729–736. 2007.
70	Dong LH, Wen JK, Miao SB, et al: Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia. Cell Res. 20:1252–1262. 2010.PubMed/NCBI
71	Way TD, Lee JC, Kuo DH, et al: Inhibition of epidermal growth factor receptor signaling by Saussurea involucrata, a rare traditional Chinese medicinal herb, in human hormone-resistant prostate cancer PC-3 cells. J Agric Food Chem. 58:3356–3365. 2010.PubMed/NCBI
72	Hahm ER and Singh SV: Honokiol causes G0–G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol Cancer Ther. 6:2686–2695. 2007.
73	Tao R, Lu L, Zhang R, Hu J, Ni J and Shen W: Triptolide inhibits rat vascular smooth muscle cell proliferation and cell cycle progression via attenuation of ERK1/2 and Rb phosphorylation. Exp Mol Pathol. 90:137–142. 2011. View Article : Google Scholar : PubMed/NCBI
74	Shan BE, Zeki K, Sugiura T, Yoshida Y and Yamashita U: Chinese medicinal herb, Acanthopanax gracilistylus, extract induces cell cycle arrest of human tumor cells in vitro. Jpn J Cancer Res. 91:383–389. 2000.
75	Xiao XY, Hao M, Yang XY, et al: Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. Cancer Lett. 302:69–75. 2011. View Article : Google Scholar : PubMed/NCBI
76	Kametani S, Oikawa T, Kojima-Yuasa A, et al: Mechanism of growth inhibitory effect of cape aloe extract in ehrlich ascites tumor cells. J Nutr Sci Vitaminol (Tokyo). 53:540–546. 2007. View Article : Google Scholar : PubMed/NCBI
77	Yang P, Cartwright C, Chan D, Vijjeswarapu M, Ding J and Newman RA: Zyflamend-mediated inhibition of human prostate cancer PC3 cell proliferation: effects on 12-LOX and Rb protein phosphorylation. Cancer Biol Ther. 6:228–236. 2007. View Article : Google Scholar : PubMed/NCBI
78	Liu H, Zang C, Emde A, et al: Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur J Pharmacol. 591:43–51. 2008. View Article : Google Scholar : PubMed/NCBI
79	Yang JY, Della-Fera MA, Rayalam S and Baile CA: Enhanced effects of xanthohumol plus honokiol on apoptosis in 3T3-L1 adipocytes. Obesity (Silver Spring). 16:1232–1238. 2008. View Article : Google Scholar : PubMed/NCBI
80	Roy S, Yu Y, Padhye SB, Sarkar FH and Majumdar AP: Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21. PLoS One. 8:e685432013. View Article : Google Scholar : PubMed/NCBI
81	Yoshida H, Okumura N, Kitagishi Y, Nishimura Y and Matsuda S: Ethanol extract of rosemary repressed PTEN expression in K562 culture cells. Int J Appl Boil Pharm Technol. 2:316–322. 2011.
82	Bosviel R, Dumollard E, Déchelotte P, Bignon YJ and Bernard-Gallon D: Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS. 16:235–244. 2012. View Article : Google Scholar : PubMed/NCBI
83	Kobayashi K, Nagata E, Sasaki K, Harada-Shiba M, Kojo S and Kikuzaki H: Increase in secretory sphingomyelinase activity and specific ceramides in the aorta of apolipoprotein E knockout mice during aging. Biol Pharm Bull. 36:1192–1196. 2013. View Article : Google Scholar : PubMed/NCBI